A major ocean current in the Arctic, the Beaufort Gyre, is changing rapidly due to climate warming—and this could trigger a ...

The stock price didn't jump after Gyre Therapeutics ... should look for improved cashflow relative to profit in the current year, if that is indeed the case. That might leave you wondering ...

Gyre Therapeutics (NASDAQ:GYRE – Get Free Report) last posted its quarterly earnings data on Monday, March 17th. The company reported $0.01 EPS for the quarter, missing the consensus estimate of ...

SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biotechnology company focused on organ fibrosis, today announced that ...

Gyre Therapeutics' stock is volatile - I'm upholding ... from five main classes of drugs aiming to reach the market in the current MASH landscape: Farnesoid X receptor agonists, fibroblast grow ...

Gyre Therapeutics, Inc. (NASDAQ:GYRE – Get Free Report)’s stock price gapped down prior to trading on Tuesday following a weaker than expected earnings announcement. The stock had previously ...

In a report released today, Robert LeBoyer from Noble Financial reiterated a Buy rating on Gyre Therapeutics (GYRE – Research Report), with a price target of $20.00. The company’s shares ...

With the new trial, Gyre aims to explore the drug’s potential in mitigating lung injury progression in cancer patients. The company’s impressive 96% gross profit margin and healthy current ...

Have you been paying attention to current events recently? See how many of these 10 questions you can get right. Are cellphones the cause of increased student conflicts? If so, what can be done to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Investing.com - The U.S. dollar edged higher in thin holiday-affected trade Monday, as traders digested the impact of last week’s central bank decisions, with a speech by Fed Chair Jerome Powell ...